Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Clinical trial NCT00949949 · COMPLETED

Trial details

NCT number: NCT00949949
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cholangiocarcinoma of the Gallbladder Localized Gallbladder Cancer Unresectable Gallbladder Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2009-09-01
Primary completion: 2014-07-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.